China SXT Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|
Revenue | $494 | $494 | $939 |
Gross Profit | 132 | 132 | 185 |
EBITDA | 3,678 | 3,678 | -4,623 |
EBIT | 3,628 | 3,628 | -4,725 |
Net Income | 3,298 | 3,298 | -9,696 |
Net Change In Cash | 494 | 494 | 939 |
Free Cash Flow | -677 | -677 | -289 |
Cash | 12,070 | 12,070 | 11,465 |
Basic Shares | 1,233 | 1,233 | 501 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $1,928 | $1,971 | $2,602 | $4,777 |
Gross Profit | 553 | 426 | 1,251 | 2,839 |
EBITDA | -2,351 | -5,207 | -5,051 | -1,851 |
EBIT | -2,554 | -5,457 | -5,371 | -2,197 |
Net Income | -3,098 | -5,934 | -5,736 | -2,748 |
Net Change In Cash | 1,928 | 1,971 | 2,602 | 4,777 |
Free Cash Flow | -1,935 | -151 | 205 | -1,409 |
Cash | 12,077 | 17,368 | 15,524 | 13,333 |
Basic Shares | 867 | 266 | 41 | 28 |
Earnings Calls
| Quarter | EPS |
|---|---|
2022-06-30 | -$2.03 |
2021-12-31 | -$0.20 |
2021-06-30 | -$0.27 |
2020-12-31 | $0.10 |
